These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3139389)

  • 1. [Short-acting fibrinolysis in the etiology of venous thrombosis].
    Petäjä J; Myllylä G; Rasi V; Vahtera E
    Duodecim; 1988; 104(5):317-24. PubMed ID: 3139389
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coagulation physiological findings in thrombosis].
    Nilsson IM; Cronberg S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(2):124-9. PubMed ID: 50976
    [No Abstract]   [Full Text] [Related]  

  • 3. Perioperative fibrinolytic kinetics.
    Gomez MJ; Carroll RC; Hansard RM; Goldman MH
    Curr Surg; 1987; 44(6):476-9. PubMed ID: 3123145
    [No Abstract]   [Full Text] [Related]  

  • 4. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.
    Nilsson IM; Ljungnér H; Tengborn L
    Br Med J (Clin Res Ed); 1985 May; 290(6480):1453-6. PubMed ID: 3922531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.
    Verheijen JH; Rijken DC; Chang GT; Preston FE; Kluft C
    Thromb Haemost; 1984 Jul; 51(3):396-7. PubMed ID: 6437007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular markers of hemostatic mechanisms--interaction of plasminogen activator and its inhibitor].
    Sakata Y
    Rinsho Byori; 1989 Mar; 37(3):256-60. PubMed ID: 2787424
    [No Abstract]   [Full Text] [Related]  

  • 7. Altered fibrinolysis in DVT: influence of site of sampling.
    Han P; Koay ES; Tsakok M; Aw TC; Wong LY; Pradhan M
    Thromb Haemost; 1988 Aug; 60(1):50-3. PubMed ID: 3142091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Poor fibrinolytic response to venous occlusion: defect of endothelial cells or plasma interference?].
    Stalder M; Hauert J; Bachmann F
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1462-4. PubMed ID: 6606226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor (PA-inhibitor) activity in the blood of patients with deep vein thrombosis.
    Paramo JA; de Boer A; Colucci M; Jonker JJ; Collen D
    Thromb Haemost; 1985 Oct; 54(3):725. PubMed ID: 3937271
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between preoperative status of the fibrinolytic system and occurrence of deep vein thrombosis after major abdominal surgery.
    Mellbring G; Dahlgren S; Wiman B; Sunnegårdh O
    Thromb Res; 1985 Jul; 39(2):157-63. PubMed ID: 2411000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activation and endotoxin.
    N Engl J Med; 1989 Sep; 321(13):903-4. PubMed ID: 2788817
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fibrinolytic therapy--plasminogen activator inhibitors].
    Hönigl K; Pilger E; Stark G; Bertuch H
    Vasa Suppl; 1988; 26():103-6. PubMed ID: 3144048
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is hypofibrinolysis a risk factor of thrombosis?].
    Juhan-Vague I
    Rev Prat; 1989 Nov; 39(26):2337-9. PubMed ID: 2512628
    [No Abstract]   [Full Text] [Related]  

  • 14. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.
    Colucci M; Altomare DF; Chetta G; Triggiani R; Cavallo LG; Semeraro N
    Thromb Haemost; 1988 Aug; 60(1):25-9. PubMed ID: 3142090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liberation of plasminogen activators].
    Klöcking HP; Bock G; Drawert J; Hinsenbrock KP; Kaiser B; Sedlarik U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):404-24. PubMed ID: 63428
    [No Abstract]   [Full Text] [Related]  

  • 17. [Endothelium, thrombosis and fibrinolysis].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1997 Dec; 47(20):2227-31. PubMed ID: 9616910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J; Rueda F
    Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of fibrinolysis in thrombotic thrombocytopenic purpura.
    Kwaan HC
    Semin Hematol; 1987 Apr; 24(2):101-9. PubMed ID: 3110958
    [No Abstract]   [Full Text] [Related]  

  • 20. The fibrinolytic enzyme system and its role in the etiology of thromboembolic disease.
    Wiman B; Hamsten A
    Semin Thromb Hemost; 1990 Jul; 16(3):207-16. PubMed ID: 2146744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.